The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer

E-session 398 / CME accredited Add to My Agenda

Expert:

Ettore Seregni, expert of session 'The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer'

Ettore Seregni, Head of Nuclear Medicine Therapy and Endocrinology
National Cancer Institute
Milan, Italy

Discussant: Niklaus Schaefer, Medical Oncologist and Nuclear Physician
University Hospital of Canton Vaud, Lausanne, Switzerland

View slides

Enter the recorded session

Share on:

In order to access to the CME test, please check the minimum system requirements.
If the WebEx platform is used in temporary mode, access to the CME test can not be guaranteed

Check the minimum system requirements

01
Jun 2017
18:15-19:00 CET

Top